tiprankstipranks
Alpha Teknova (TKNO)
NASDAQ:TKNO
US Market
Want to see TKNO full AI Analyst Report?

Alpha Teknova (TKNO) Earnings Dates, Call Summary & Reports

281 Followers

Earnings Data

Report Date
Aug 12, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.08
Last Year’s EPS
-0.07
Same Quarter Last Year
Moderate Buy
Based on 5 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 06, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed a generally positive tone: the company reported solid top-line growth (13% YoY), a pronounced 85% increase in Clinical Solutions, improved gross margin and adjusted EBITDA, operational scaling initiatives, and disciplined commercial investments aimed at driving ~20% growth in 2027. However, material risks remain including a persistent GAAP net loss, continued negative adjusted EBITDA, modest Lab Essentials growth, high fixed-cost structure with a roughly 70% marginal cash drop-through, and dependence on broader biotech funding recovery. Management reiterated a conservative 2026 guide while outlining a credible plan for improved profitability and growth in 2027.
Company Guidance
The company reiterated 2026 revenue guidance of $42–$44 million (midpoint ≈ 6% growth vs. 2025), expects full‑year gross margin in the mid‑30s, plans roughly $2.0 million of incremental annual commercial spend (split between sales and marketing) with impact visible by early 2027, and continues to target full‑year free cash outflow of less than $10.0 million; Q1 specifics included revenue topping $11.0 million (up 13% YoY) with Lab Essentials $8.4M (+3%) and Clinical Solutions $2.1M (+85%), gross profit $3.8M (34.2% margin), operating expenses $8.1M, net loss $4.6M (−$0.08/share), adjusted EBITDA −$2.0M (vs. −$2.5M prior year), cash of $17.8M and total borrowings $13.2M, a ~70% marginal cash drop‑through rate on incremental revenue, and a stated ~$52–$57M annualized revenue threshold to reach adjusted EBITDA positivity (with the company aiming for a positive adjusted EBITDA quarter by 2027).
Overall Revenue Growth
Total revenue grew 13% year over year in Q1 2026; this is the first Q1 in nearly three years with revenue above $11 million.
Clinical Solutions Surge
Clinical Solutions revenue increased 85% year over year to $2.1 million (from $1.2 million), driven by an increased number of customers and higher average revenue per customer; management characterized the growth as broad-based rather than a single large order.
Lab Essentials Stability
Lab Essentials revenue was $8.4 million, up 3% year over year from $8.1 million, supported by higher average revenue per customer despite a decreased customer count.
Improved Profitability Metrics
Gross profit rose to $3.8 million from $3.0 million year over year; gross margin improved to 34.2% from 30.7% in Q1 2025. Adjusted EBITDA improved to negative $2.0 million from negative $2.5 million.
Cash Flow and Balance Sheet Improvements
Free cash outflow improved to $3.6 million from $4.3 million year over year (approximately a 16% improvement). Cash, cash equivalents, and short-term investments totaled $17.8 million with total borrowings of $13.2 million as of 03/31/2026.
Operational and Process Enhancements
Operational initiatives included tripling single-batch size for high-volume bottle production and implementing an automated aseptic filling line to scale volumes and reduce labor hours per unit; 90 of over 3,000 paper batch records migrated to digital to improve analytics, documentation quality, and standardization.
Commercial Investment and 2027 Growth Target
Company initiated roughly $2 million annual increase in commercial spend (sales and marketing) starting in 2026 to drive lead generation and field coverage; management expects to see revenue impact by early 2027 and is targeting approximately 20% revenue growth in 2027.
Reiterated 2026 Guidance with Manageable Expectations
Management reiterated 2026 revenue guidance of $42 million to $44 million (midpoint implying ~6% growth versus 2025) and expects gross margin in the mid-30s for the full year; free cash outflow is expected to be less than $10 million for full-year 2026 despite increased commercial investment.

Alpha Teknova (TKNO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TKNO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 12, 2026
2026 (Q2)
-0.08 / -
-0.07
May 06, 2026
2026 (Q1)
-0.09 / -0.08
-0.0911.11% (<+0.01)
Feb 26, 2026
2025 (Q4)
-0.09 / -0.09
-0.1118.18% (+0.02)
Nov 06, 2025
2025 (Q3)
-0.09 / -0.08
-0.1546.67% (+0.07)
Aug 07, 2025
2025 (Q2)
-0.10 / -0.07
-0.1346.15% (+0.06)
May 08, 2025
2025 (Q1)
-0.11 / -0.09
-0.255.00% (+0.11)
Mar 04, 2025
2024 (Q4)
-0.12 / -0.11
-0.2657.69% (+0.15)
Nov 07, 2024
2024 (Q3)
-0.11 / -0.15
-0.3455.88% (+0.19)
Aug 13, 2024
2024 (Q2)
-0.16 / -0.13
-0.2548.00% (+0.12)
May 13, 2024
2024 (Q1)
-0.24 / -0.20
-0.3135.48% (+0.11)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TKNO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 06, 2026
$3.64$4.00+9.89%
Feb 26, 2026
$2.28$2.58+13.16%
Nov 06, 2025
$4.81$4.71-2.08%
Aug 07, 2025
$4.34$4.23-2.53%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Alpha Teknova (TKNO) report earnings?
Alpha Teknova (TKNO) is schdueled to report earning on Aug 12, 2026, After Close (Confirmed).
    What is Alpha Teknova (TKNO) earnings time?
    Alpha Teknova (TKNO) earnings time is at Aug 12, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TKNO EPS forecast?
          TKNO EPS forecast for the fiscal quarter 2026 (Q2) is -0.08.